Caren Deardorf

Caren Deardorf

Direktor/Vorstandsmitglied bei
Pan Mass Challenge
61 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Caren Deardorf is currently Director at Pan Mass Challenge, Independent Director at Crinetics Pharmaceuticals, Inc. since 2022, and Secretary & Director at Pan Massachusetts Challenge, Inc. Former roles include Director at Can Do Multiple Sclerosis, Independent Director at Neurosense Therapeutics Ltd. from 2021 to 2024, Chief Commercial & Strategy Officer at Editas Medicine, Inc. from 2023 to 2025, Chief Commercial Officer at Magenta Therapeutics, Inc. from 2021 to 2023, Chief Commercial Officer at Ohana Biosciences, Inc. from 2019 to 2021, and VP-Product Development & Commercialization at Biogen, Inc. from 2017 to 2019.
Education includes undergraduate studies at Tufts University and an MBA from F.W.
Olin Graduate School of Business.

Aktive Positionen von Caren Deardorf

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von Caren Deardorf

UnternehmenPositionEnde
CRINETICS PHARMACEUTICALS Direktor/Vorstandsmitglied 01.09.2026
EDITAS MEDICINE, INC. Corporate Officer/Principal 01.04.2025
NEUROSENSE THERAPEUTICS LTD. Direktor/Vorstandsmitglied 27.06.2024
MAGENTA THERAPEUTICS Corporate Officer/Principal 07.02.2023
Corporate Officer/Principal 01.05.2021
Sehen Sie sich die Erfahrung von Caren Deardorf im Detail an

Ausbildung von Caren Deardorf

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

71

Beziehungen ersten Grades

11

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen11

Health Technology

Consumer Services

Commercial Services

Commercial Services

Health Technology

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

  1. Börse
  2. Insiders
  3. Caren Deardorf